Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Liver synthetic and metabolic function can only be optimised by the growth of cells within a supportive liver matrix. This can be achieved by the utilisation of decellularised human liver tissue. Here we demonstrate complete decellularization of whole human liver and lobes to form an extracellular matrix scaffold with a preserved architecture. Decellularized human liver cubic scaffolds were repopulated for up to 21 days using human cell lines hepatic stellate cells (LX2), hepatocellular carcinoma (Sk-Hep-1) and hepatoblastoma (HepG2), with excellent viability, motility and proliferation and remodelling of the extracellular matrix. Biocompatibility was demonstrated by either omental or subcutaneous xenotransplantation of liver scaffold cubes (5 × 5 × 5 mm) into immune competent mice resulting in absent foreign body responses. We demonstrate decellularization of human liver and repopulation with derived human liver cells. This is a key advance in bioartificial liver development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Peracetic acid (PAA) at a concentration of 0.1 % is the most commonly used acid for decellularization and sterilization of liver; however, it has adverse effects on GAGs, growth factors, and the mechanical characteristics of ECM [12,15,[103], [104], [105], [106], [107]].”
From Liver tissue engineering using decellularized scaffolds: Current progress, challenges, and opportunities (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HepG2 cells efficiently repopulate decellularized rat, porcine, and human livers while retaining their function and proliferative capacity [14,15,204].”
From Liver tissue engineering using decellularized scaffolds: Current progress, challenges, and opportunities (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a decellularized extracellular matrix (dECM) scaffold in which all cells are removed from the organ but the organ-specific architectures and biochemical niches remain has been a promising substrate for liver tissue engineering4,5.”
From Bioengineered liver crosslinked with nano-graphene oxide enables efficient liver regeneration via MMP suppression and immunomodulation (2023) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring the global burden of disease
Murray, C. J. L., & Lopez, A. D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1201534 · Cited by 1,818
Uygun, B. E., Soto-Gutierrez, A., Yagi, H., Izamis, M.-L., Guzzardi, M. A., Shulman, C., Milwid, J., Kobayashi, N., Tilles, A., Berthiaume, F., et al. (2010) · Nature Medicine · doi:10.1038/nm.2170 · Cited by 1,370
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation
Fox, I. J., Chowdhury, J. R., Kaufman, S. S., Goertzen, T. C., Chowdhury, N. R., Warkentin, P. I., Dorko, K., Sauter, B. V., & Strom, S. C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382004 · Cited by 1,023
Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis
Xu, L., Hui, A. Y., Albanis, E., Arthur, M. J., O’Byrne, S. M., Blaner, W. S., Mukherjee, P., Friedman, S. L., & Eng, F. J. (2005) · Gut · doi:10.1136/gut.2004.042127 · Cited by 1,014
The use of whole organ decellularization for the generation of a vascularized liver organoid
Baptista, P. M., Siddiqui, M. M., Lozier, G., Rodriguez, S. R., Atala, A., & Soker, S. (2011) · Hepatology · doi:10.1002/hep.24067 · Cited by 681
The utility of marginal donors in liver transplantation
Busuttil, R. W., & Tanaka, K. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50105 · Cited by 662
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a
Muraca, M., Gerunda, G., Neri, D., Vilei, M.-T., Granato, A., Feltracco, P., Meroni, M., Giron, G., & Burlina, A. B. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07529-3 · Cited by 383
Decellularized tissue-engineered blood vessel as an arterial conduit
Quint, C., Kondo, Y., Manson, R. J., Lawson, J. H., Dardik, A., & Niklason, L. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019506108 · Cited by 368
A Whole-Organ Regenerative Medicine Approach for Liver Replacement
Soto-Gutierrez, A., Zhang, L., Medberry, C., Fukumitsu, K., Faulk, D., Jiang, H., Reing, J., Gramignoli, R., Komori, J., Ross, M., et al. (2011) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2010.0698 · Cited by 311
Cited by
Items 401–424 of 424
Morini, S., Barbancho, S. M., Blanes-Rodríguez, Á., Plá-Palacín, I., Sainz‐Arnal, P., Sánchez‐Romero, N., Falceto, M. V., Mitjana, O., Romero, A., del Rio-Nechaevsky, M., et al. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1625999
Biliary tree stem cell transplantation
Paradiso, S., Cremisini, F., Franchitto, M., Carpino, G., & Cardinale, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-823524-9.00014-9
Human hepatocyte transplantation
Nulty, J., Anand, H., & Dhawan, A. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-823524-9.00012-5
Whole-liver bioengineering: The future of transplantation medicine
Marques, D., Romero, N. S., Barbancho, S. M., Blanes-Rodríguez, Á., Arnal, P., Almeida, H., Dachary, P. R., & Baptista, P. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-823524-9.00018-6
Beyond Pluripotency Harnessing Organ Specific Stem Cells for Therapeutic Innovation – A Review
Mahajan, P., Lale, P., Mahajan, S., Mahajan, S. P., Gupta, J., & Dsouza, M. (2025) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2025.v07i06.60284
“Similarly, hepatic MSCs preconditioned within liver-like matrices enriched with collagen IV and laminin show augmented anti-fibrotic , hepatoprotective , and metabolic support properties, attributed to preserved niche-specific signaling pathways [177, 190].”
Development of a supercritical CO2 decellularization technology
Loczenski, R. (2020) · Nottingham ePrints (University of Nottingham) · Cited by 1
Tanneberger, A. E. (2021) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)
Salman, F. T. (2026) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-032-10024-5_8
Biomaterials Degradation and Bioabsorbability: Biomedical Potentials of Marine Enzymes
Guo, K. W. (2026) · Springer eBooks · doi:10.1007/978-3-319-48281-1_160-2
Induced Pluripotent Stem cell based in-vitro model of embryonic development
Khadim, R. R. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.15083/0002011008
Topology Before Function: The Bauplan as the Structural Limit of Biological ExecutionPreprint
Rahman, T. (2026) · Preprints.org · doi:10.20944/preprints202604.0864.v1
The Role of Extracellular Matrix of Fat Graft
Hoffmann, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-01711-6_12
Applications of decellularized plant tissues in regenerative medicine and tissue engineering
Linz, A., Wei, H., & Bomble, Y. J. (2026) · Exploration of BioMat-X · doi:10.37349/ebmx.2026.101367
Recellularized Rat Liver Scaffold: An In Vitro Model for Biosafety Assessments
Kalinovskaia, O., Poliakov, M., & Karabekian, Z. I. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-1524-9.ch008
A review on decellularization scaffolding for liver regeneration in transplantation
Liu, Y., Liu, S.-Y., Chung, W.-Y., Bowrey, D. J., & Huang, K. (2026) · Hepatoma Research · doi:10.20517/2394-5079.2026.09
Biomaterial-based Platforms for Modeling the Pre-metastatic Niche
Halim, M. S. A., Nadernezhad, A., Kopecky, C., Hauser, S., Kilian, K. A., & Loessner, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30151-3.00005-x
Hattersley, J., Aughton, K., Coupland, S. E., & Kalirai, H. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101493
Lai, Q., Quaresima, S., Matrascia, C., & Melandro, F. (2026) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2026.2750985
From Tissue Engineering to Organ Engineering
Brennen, B. R., & Atala, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30151-3.00014-0
肝組織培養への応用を目指した酸素生成培養基材の調製と酸素生成能の定量解析
励, 騰. (2026) · QIR (Kyushu University Institutional Repository) (Kyushu University)
Engineering in vitro models of liver fibrosis
Berlin, D., & Smith, Q. (2026) · Matrix Biology Plus · doi:10.1016/j.mbplus.2026.100209
Metadata
- Authors
- Mazza, G., Rombouts, K., Rennie Hall, A., Urbani, L., Vinh Luong, T., Al-Akkad, W., Longato, L., Brown, D., Maghsoudlou, P., Dhillon, A. P., Fuller, B., Davidson, B., Moore, K., Dhar, D., De Coppi, P., Malago, M., & Pinzani, M.
- Affiliations
- University College London (GB)
- Great Ormond Street Hospital (GB)
- The Royal Free Hospital (GB)
- Royal Free London NHS Foundation Trust (GB)
- Corresponding author
- Mazza, Giuseppe
- ORCID
- Venue
- Scientific Reports
- Published
- 2015-08-07
- Volume
- 5
- Issue
- 1
- Pages
- 13079-13079
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4528226
- OpenAlex
- W1061628335
- Cited by
- 415
- References
- 34
- Citations by year
- 2026: 19 · 2025: 25 · 2024: 23 · 2023: 34 · 2022: 37 · 2021: 45 · 2020: 54 · 2019: 54 · 2018: 42 · 2017: 53 · 2016: 25 · 2015: 3
- FWCI
- 41.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Explore Bristol Research (submittedVersion)
- Funders
- Wellcome Trust
- National Institute for Health and Care Research
- Great Ormond Street Hospital Charity
- Medical Research Council
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Keywords
- extracellular matrix scaffolds, 3D scaffolds, liver transplantation, bioartificial liver, hepatic stellate cells, hepatocellular carcinoma cells, hepatoblastoma cells, xenotransplantation, biocompatibility, foreign body reaction, extracellular matrix remodeling
- MeSH terms
- Animals, Biomedical Engineering, Extracellular Matrix, Carcinoma, Hepatocellular, Humans, Liver, Male, Mice, Inbred C57BL, Transplantation, Heterologous, Liver Transplantation, Hepatoblastoma, Hepatocytes, Tissue Engineering, Cell Line, Tumor, Mice, Tissue Scaffolds, Hepatic Stellate Cells, Hep G2 Cells, Bioengineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.